Retrospective Study
Copyright ©The Author(s) 2022.
World J Diabetes. Sep 15, 2022; 13(9): 776-785
Published online Sep 15, 2022. doi: 10.4239/wjd.v13.i9.776
Table 3 Comparison of adverse outcomes between two groups
Adverse outcomes
Right age group (n = 377)
Older group (n = 206)
t/χ2
P
Preterm birth40 (10.61)26 (12.62)0.370.464
Polyhydramnios5 (1.32)8 (3.88)3.9960.046
Oligohydramnios32 (8.49)10 (4.85)2.6310.105
Fetal distress40 (10.61)10 (4.85)5.6280.018
Macrosomia8 (2.12)2 (0.97)1.0470.306
Umbilical cord around the neck125 (33.16)59 (28.64)1.2580.262
Neonatal death events3 (0.80)1 (0.49)0.1880.664
Neonatal hospitalization4 (0.27)1 (0.49)0.5190.471
Neonatal aspiration pneumonia3 (0.80)2 (0.97)0.0480.827
Neonatal Hypoglycemia4 (0.27)2 (0.97)0.0110.918
neonatal jaundice5 (1.32)2 (0.97)0.1420.706
Postpartum hemorrhage (mL)318.62 ± 97.02362.20 ± 175.923.8610.001